CCNI2 promotes pancreatic cancer through PI3K/AKT signaling pathway

CCNI2 promotes pancreatic cancer through PI3K/AKT signaling pathway

Globally, pancreatic cancer is recognized as one of the deadliest malignancies that lacks effective targeted therapies. This study aims to explore the role of cyclin I-like protein (CCNI2), a homolog of cyclin I (CCNI), in the progression of pancreatic cancer, thereby providing a theoretical basis...

Full description

Bibliographic Details
Main Authors: Bingyang Hu, Wenzhi Zhang, Changsheng Zhang, Chonghui Li, Ning Zhang, Ke Pan, Xinlan Ge, Tao Wan
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2024-03-01
Series:Biomolecules & Biomedicine
Subjects:
Pancreatic cancer
cyclin I-like protein (CCNI2)
prognosis
phenotype
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/9337

Internet

https://www.bjbms.org/ojs/index.php/bjbms/article/view/9337

Similar Items